First Time Loading...

Harpoon Therapeutics Inc
NASDAQ:HARP

Watchlist Manager
Harpoon Therapeutics Inc Logo
Harpoon Therapeutics Inc
NASDAQ:HARP
Watchlist
Price: 23.01 USD
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

HARP Price Targets Summary
Harpoon Therapeutics Inc

Wall Street analysts forecast HARP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HARP is 24.79 USD .

HARP Lowest Forecast
Wall Street Target
Not Available
HARP Average Forecast
Wall Street Target
24.79 USD
8% Upside
HARP Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
24.79 USD
8% Upside
Highest
Price Target
Not Available
Harpoon Therapeutics Inc Competitors:
Price Targets
I
086890
Isu Abxis Co Ltd
122% Upside
CIR
Circassia Group PLC
29% Upside
EXEL
Exelixis Inc
24% Upside
300406
Beijing Strong Biotechnologies Inc
19% Upside
I
086890
Isu Abxis Co Ltd
122% Upside
CIR
Circassia Group PLC
29% Upside
EXEL
Exelixis Inc
24% Upside
300406
Beijing Strong Biotechnologies Inc
19% Upside
KURN
Kuros Biosciences AG
212% Upside
ADCT
ADC Therapeutics SA
121% Upside
PRAX
Praxis Precision Medicines Inc
158% Upside
688319
Chengdu Olymvax Biopharmaceuticals Inc
169% Upside

Revenue
Forecast

Revenue Estimate
Harpoon Therapeutics Inc

For the last 5 years the compound annual growth rate for Harpoon Therapeutics Inc's revenue is 114%. The projected CAGR for the next 4 years is 10%.

114%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Harpoon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Harpoon Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
What are analyst estimates?

See Also

Summary
HARP intrinsic value, competitors valuation, and company profile.
DCF Valuation
HARP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HARP stock valuation using valuation multiples.
Wall Street Estimates
HARP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HARP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HARP's stock price target?
Price Target
24.79 USD

According to Wall Street analysts, the average 1-year price target for HARP is 24.79 USD .

What is Harpoon Therapeutics Inc's Revenue forecast?
Projected CAGR
10%

For the last 5 years the compound annual growth rate for Harpoon Therapeutics Inc's revenue is 114%. The projected CAGR for the next 4 years is 10%.

ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.